Skip to main content
. 2016 Nov 23;90:187–194. doi: 10.1016/j.bios.2016.11.051

Fig. 4.

Fig. 4.

Clinical utility of the iROAD assay. Analysis of 63 clinical nasopharyngeal samples from 13 IFN-A patients (A), 7 IFN-B patients (B), 17 HCoV-OC43 patients (C), 5 HCoV-229E patients (D), 6 RSV-A patients (E), and 15 RSV-B patients (F) with the matched primers in 20 min. The red dots represent as a negative control by non-specific binding. Error bars indicate standard deviation from the mean, based on at least 3 independent experiments. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)